CLINICAL_TRIALS
trial_result
· 2021-10-26
Clinical Trial Update: Afamelanotide in Patients Suffering With Acne Vulgaris [Phase 2]
Summary
Phase 2 clinical trial update for afamelanotide in acne vulgaris has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2021-10-26